- Pharmaceutical packaging plays a significant role in the pharmaceutical industry for the safety of the drugs and medicine against all unfavourable external influences. These influences can change the properties of the drug or medicine and cause mechanical damage, physical damage, biological contamination and degradation and also counterfeiting
- The Europe pharmaceutical packaging market is expected to rise in demand due to the high demand for drug delivery devices and blister packaging
- Germany dominates the Europe pharmaceutical packaging market, accounting for the largest regional share of approximately 26.32% in 2024. This leadership is attributed to its strong pharmaceutical manufacturing base, high healthcare expenditure, and advanced packaging technology adoption. The presence of leading pharma companies and a robust regulatory environment further reinforces Germany's position as a key driver in the region's packaging evolution
- The Poland is expected to witness the highest growth rate in the Europe Pharmaceutical Packaging market, projected to register a CAGR of 7.5% and account for a market share of 5.12% in 2025. This growth is driven by increasing pharmaceutical manufacturing activities, rising healthcare investments, and a growing demand for modern, regulation-compliant packaging solutions
- In 2025, the Plastics segment is expected to dominate the material type segment of the Europe Pharmaceutical Packaging market, holding a market share of approximately 52.3%. This dominance is driven by plastics' versatility, lightweight nature, and cost-effectiveness, along with their suitability for a wide range of pharmaceutical products such as blister packs, bottles, syringes, and pouches
